stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Tyra Biosciences IncTYRA
$21.240.63%-0.135

Tyra Biosciences Inc (TYRA)

Date: 2026-11-04 16:00O: 21.91H: 21.91L: 20.78C: 21.18Vol: 253.6k
Precedente Chiudi:
$21.37
Aprire:
$21.91
Volume 24 ore:
197,447
Volume relativo:
0.33
Capitalizzazione di mercato:
$1.46B
Reddito:
-
Utile/perdita netta:
-$131.11M
Rapporto P/E:
-
EPS:
-$2.17
Flusso di cassa netto:
-$102.47M
1W Prestazione:
-2.37%
1M Prestazione:
+3.94%
6M Prestazione:
-39.57%
1Y Prestazione:
+41.57%
Intervallo 1D:
$20.78$21.91
Intervallo di 1 settimana:
$20.32$22.37
Portata 52W:
$13.35$40.65

Profilo aziendale di Tyra Biosciences Inc (TYRA)

Nome
Tyra Biosciences Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
(619) 728-4760
Indirizzo
2656 STATE STREET, CARLSBAD, USA
Dipendente
87
X
-
Prossima data di guadagno
2026-11-04
Ultimi documenti SEC
SEC
Discussioni di TYRA su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Tyra Biosciences Inc Azioni (TYRA) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-05-19IniziatoWolfe ResearchPeer Perform
2026-04-15IniziatoGuggenheimBuy
2026-04-06IniziatoCanaccord GenuityBuy
2026-02-24IniziatoCantor FitzgeraldOverweight

Tyra Biosciences Inc Azioni (TYRA) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)--0.000.000.00
Research and development USD (M)102.9380.0862.5243.0120.64
Operating expenses USD (M)132.76104.1879.9558.9326.29
Operating income USD (M)-132.76-104.18-79.95-58.93-26.29
Income before tax USD (M)---69.13-55.32-26.29
Income tax expense USD (M)0.000.000.000.000.00
Net income USD (M)-119.95-86.48-69.13-55.33-26.29
Basic EPS USD/shares-2.01-1.51-1.62-1.32-
Diluted EPS USD/shares-2.01-1.51-1.62-1.32-
Basic weighted shares shares (M)59.6057.2242.7041.88-
Diluted weighted shares shares (M)59.6057.2242.7041.88-

Tyra Biosciences Inc Azioni (TYRA) insider trading

  • Verjee RehanSep 09 '26
    Director
    Transazione
    Buy
    Costo
    $20.58
    #Azioni
    972
    Valore ($)
    20,000
    #Azioni Totale
    972
  • Shareholder
    Transazione
    Proposed Sale
    Costo
    $30.94
    #Azioni
    308,379
    Valore ($)
    9,541,246
    #Azioni Totale
    0
  • Shareholder
    Transazione
    Proposed Sale
    Costo
    $33.41
    #Azioni
    300,000
    Valore ($)
    10,023,000
    #Azioni Totale
    0
  • Daniel BensenMay 12 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $34.25
    #Azioni
    8,000
    Valore ($)
    274,000
    #Azioni Totale
    0
  • Daniel BensenApr 13 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $35.62
    #Azioni
    8,000
    Valore ($)
    285,000
    #Azioni Totale
    0
  • GILLA KAPLANMar 26 '26
    Director
    Transazione
    Proposed Sale
    Costo
    $37.75
    #Azioni
    53,172
    Valore ($)
    2,007,153
    #Azioni Totale
    0
  • GILLA KAPLANMar 25 '26
    Director
    Transazione
    Proposed Sale
    Costo
    $36.97
    #Azioni
    14,295
    Valore ($)
    528,506
    #Azioni Totale
    0
  • KAPLAN GILLAMar 25 '26
    Director
    Transazione
    Option Exercise
    Costo
    $2.25
    #Azioni
    14,295
    Valore ($)
    32,164
    #Azioni Totale
    42,526
  • KAPLAN GILLAMar 25 '26
    Director
    Transazione
    Sale
    Costo
    $36.97
    #Azioni
    14,295
    Valore ($)
    528,506
    #Azioni Totale
    28,231
  • Daniel BensenMar 12 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $35.38
    #Azioni
    8,000
    Valore ($)
    283,000
    #Azioni Totale
    0
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Verjee RehanDirectorSep 09 '26Buy$20.5897220,000972
NEXTECH VI ONCOLOGY SCSPShareholderJun 26 '26Proposed Sale$30.94308,3799,541,2460
NEXTECH VI ONCOLOGY SCSPShareholderJun 01 '26Proposed Sale$33.41300,00010,023,0000
Daniel BensenOfficerMay 12 '26Proposed Sale$34.258,000274,0000
Daniel BensenOfficerApr 13 '26Proposed Sale$35.628,000285,0000
GILLA KAPLANDirectorMar 26 '26Proposed Sale$37.7553,1722,007,1530
GILLA KAPLANDirectorMar 25 '26Proposed Sale$36.9714,295528,5060
KAPLAN GILLADirectorMar 25 '26Option Exercise$2.2514,29532,16442,526
KAPLAN GILLADirectorMar 25 '26Sale$36.9714,295528,50628,231
Daniel BensenOfficerMar 12 '26Proposed Sale$35.388,000283,0000

Tyra Biosciences Inc Borsa (TYRA) Ultime notizie

Oct 27, 2026
Oct 27, 2026
Oct 19, 2026
Oct 19, 2026
Oct 18, 2026
Oct 18, 2026
Oct 17, 2026
Oct 17, 2026
Oct 16, 2026
Oct 16, 2026
Oct 13, 2026
Oct 13, 2026
Oct 06, 2026
Oct 06, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 20, 2026
Sep 20, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 15, 2026
Sep 15, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 11, 2026
Sep 11, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026

Simile a TYRA